Survivors of infant atypical teratoid/rhabdoid tumors present with severely impaired cognitive functions especially for fluid intelligence and visual processing: data from the German brain tumor studies
Pediatric Blood & Cancer · 2024
DOI: 10.1002/pbc.30910 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2024. Verfasst von Thomas Traunwieser und 27 weiteren Autor:innen. Beteiligte Einrichtung: Swabian Children's Cancer Center, Pediatrics and Adolescent Medicine, University Hospital Augsburg, Augsburg, Germany. Hauptthemen laut MEDLINE: Rhabdoid Tumor, Teratoma, Brain Neoplasms, Central Nervous System Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Förderkreis für krebskranke Kinder im Allgäu e.V., Kinderkrebshilfe Königswinkel e.V., Elterninitiative krebskranker Kinder Augsburg-Lichtblicke e.V..
Abstract (Originalsprache)
Background
The contribution of tumor type, multimodal treatment, and other patient‐related factors upon long‐term cognitive sequelae in infant brain tumor survivors remains undefined. We add our retrospective analysis of neuropsychological and quality of survival (QoS) outcome data of survivors of atypical teratoid/rhabdoid tumors (ATRT) and extracranial malignant rhabdoid tumors of the soft tissues (eMRT) and kidneys (RTK) treated within the same framework. Neuropsychological data from children with ATRT were compared to data from children with non‐irradiated low‐grade glioma (LGG). Patients and methods Following surgery, patients (0–36 months at diagnosis) had received radio‐chemotherapy (up to 54 Gy; ATRT: n = 13; eMRT/RTK: n = 7), chemotherapy only (LGG: n = 4; eMRT/RTK: n = 1) or had been observed (LGG: n = 11). Neuropsychological evaluation employing comparable tests was performed at median 6.8 years (ATRT), 6.6 years (eMRT/RTK), and 5.2 years (LGG) post diagnosis.
Results
We detected sequelae in various domains for all tumor types. Group comparison showed impairments, specifically in fluid intelligence ( p = .041; d = 1.11) and visual processing ( p = .001; d = 2.09) in ATRT patients when compared to LGG patients. Results for psychomotor speed and attention abilities were significantly below the norm for both groups ( p < .001–.019; d = 0.79–1.90). Diagnosis predicted impairments of cognitive outcome, while sex‐ and age‐related variables did not. QoS outcome for all rhabdoid patients displayed impairments mainly in social ( p = .008; d = 0.74) and school functioning ( p = .048; d = 0.67), as well as lower overall scores in psychosocial functioning ( p = .023; d = 0.78) and quality of life ( p = .006; d = 0.79) compared to healthy controls.
Conclusion
Survivors of infant ATRT experience various late effects in cognition and QoS following multimodal treatment, while infant LGG patients without radiotherapy demonstrated comparable impairments in psychomotor and attention abilities. Early onset and multimodal treatment of rhabdoid tumors require close monitoring of neuropsychological and QoS sequelae.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Swabian Children's Cancer Center, Pediatrics and Adolescent Medicine, University Hospital Augsburg, Augsburg, Germany.
- Bavarian Cancer Research Center, Augsburg, Germany.
- Department of Pediatric Hematology and Oncology, University Hospital Würzburg, Würzburg, Germany.
- Department of Pediatric Hematology and Oncology, University Medical Center Hamburg Eppendorf, Hamburg, Germany.
- Mildred Scheel Cancer Career Center HaTriCS4, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Diagnostic and Interventional Neuroradiology, Faculty of Medicine, University of Augsburg, Augsburg, Germany.
ORCID-Profile: Thomas Traunwieser, Holger Ottensmeier, Katharina Gastberger, Martin Mynarek, Brigitte Bison, Astrid K Gnekow, Michael C Frühwald
Förderung
- Förderkreis für krebskranke Kinder im Allgäu e.V.
- Kinderkrebshilfe Königswinkel e.V.
- Elterninitiative krebskranker Kinder Augsburg-Lichtblicke e.V.
- Deutsche Kinderkrebsstiftung (DKS 2020.10)
- Deutsche Forschungsgemeinschaft (DFG FR 1516/4-1)
- Deutsche Krebshilfe (70113981)
- Kinderonkologisches Netzwerk Bayern (KIONET)
Zitieren
APA
Traunwieser, T., Loos, E., Ottensmeier, H., Gastberger, K., Nemes, K., Mynarek, M., Bison, B., Kandels, D., Neumayer, P., Neumann-Holbeck, A., Lüttich, P., Baust, K., Faulstich-Ritter, K., John, R., Kreisch, A., Landmann, J., Manteufel, E., Nest, A., Prüfe, J., …, & Frühwald, M. C. (2024). Survivors of infant atypical teratoid/rhabdoid tumors present with severely impaired cognitive functions especially for fluid intelligence and visual processing: data from the German brain tumor studies. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.30910
Vancouver
Traunwieser T, Loos E, Ottensmeier H, Gastberger K, Nemes K, Mynarek M, et al. Survivors of infant atypical teratoid/rhabdoid tumors present with severely impaired cognitive functions especially for fluid intelligence and visual processing: data from the German brain tumor studies. Pediatric Blood & Cancer. 2024. doi:10.1002/pbc.30910
BibTeX
@article{Traunwieser2024,
author = {Traunwieser, Thomas and Loos, Elena and Ottensmeier, Holger and Gastberger, Katharina and Nemes, Karolina and Mynarek, Martin and Bison, Brigitte and Kandels, Daniela and Neumayer, Petra and Neumann-Holbeck, Anne and Lüttich, Peggy and Baust, Katja and Faulstich-Ritter, Kristin and John, Rainer and Kreisch, Andrea and Landmann, Judyta and Manteufel, Eva and Nest, Alexandra and Prüfe, Jenny and Schubert, Lisa and Stamm, Walther and Timmermann, Beate and Gerss, Joachim and Rutkowski, Stefan and Schlegel, Paul-Gerhardt and Eyrich, Matthias and Gnekow, Astrid K and Frühwald, Michael C},
title = {Survivors of infant atypical teratoid/rhabdoid tumors present with severely impaired cognitive functions especially for fluid intelligence and visual processing: data from the German brain tumor studies},
journal = {Pediatric Blood & Cancer},
year = {2024},
doi = {10.1002/pbc.30910}
}
EUVIMED